{"product_id":"total-artificial-heart-owner-makes","title":"How Much Can a Total Artificial Heart Program Owner Make at $129M?","description":"\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-plus-icon.svg\" alt=\"Key Takeaways\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eVolume spreads fixed lease costs and improves team use.\u003c\/li\u003e\n\u003cli\u003eReimbursement and payer mix drive net revenue and cash.\u003c\/li\u003e\n\u003cli\u003eDevice, logistics, and ICU days can crush margin.\u003c\/li\u003e\n\u003cli\u003eReferrals and authorization quality determine usable case flow.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003csection class=\"fml-owner-metric-cards\" aria-label=\"Total Artificial Heart Program\"\u003e\u003cdiv class=\"metric-grid\"\u003e\n\u003carticle class=\"metric-card is-green\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Year 1 to Year 5 EBITDA range from the model; pre-tax and before debt, reserves, and owner draw, so it is not cash in hand.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-owner-income.svg\" alt=\"Owner income icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eOwner income\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Year 1 to Year 5 EBITDA range from the model; pre-tax and before debt, reserves, and owner draw, so it is not cash in hand.\"\u003e$8.3M–$64.3M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"EBITDA margin uses annual EBITDA divided by revenue from Year 1 to Year 5; it excludes tax, debt service, and owner pay.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-net-margin.svg\" alt=\"Net margin icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eNet margin\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"EBITDA margin uses annual EBITDA divided by revenue from Year 1 to Year 5; it excludes tax, debt service, and owner pay.\"\u003e64%–81%\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Closest target-pay proxy is Year 1 revenue from the model; actual owner pay is not provided, so this uses the opening-year plan.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-revenue-target.svg\" alt=\"Revenue for target pay icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eRevenue for target pay\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Closest target-pay proxy is Year 1 revenue from the model; actual owner pay is not provided, so this uses the opening-year plan.\"\u003e$12.9M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Hard reflects $3.4M minimum cash in Month 6, heavy capex, and a 15-month payback before the program stabilizes.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-business-difficulty.svg\" alt=\"Business difficulty icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eBusiness difficulty\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Hard reflects $3.4M minimum cash in Month 6, heavy capex, and a 15-month payback before the program stabilizes.\"\u003eHard\u003c\/strong\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to test your owner take-home?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-owner-calculator\" aria-label=\"Total Artificial Heart Program Owner Income Calculator\" data-locale=\"en-US\" data-currency=\"USD\" data-default-scenario=\"base\" data-export-filename=\"Total Artificial Heart Program Owner Income Calculator.xlsx\" data-source-site-name=\"Financial Models Lab\" data-source-site-url=\"https:\/\/financialmodelslab.com\" data-source-page-title=\"Total Artificial Heart Program Owner Income Calculator\" data-note-title=\"Planning note:\" data-note-text=\"This is a researched planning estimate, not guaranteed salary, tax advice, or owner distribution advice.\"\u003e\u003cdiv class=\"fml-owner-card\"\u003e\n\u003cheader class=\"fml-owner-header\"\u003e\u003cdiv class=\"fml-owner-heading\"\u003e\n\u003cp class=\"fml-owner-eyebrow\"\u003eOwner income calculator\u003c\/p\u003e\n\u003cp class=\"fml-owner-intro\"\u003eEstimate owner take-home and the target-pay gap from monthly revenue, margin, labor, overhead, reserves, and target pay. Use the Year 1, Year 3, and Year 5 planning cases as the default range.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-scenarios\" aria-label=\"Income scenario presets\"\u003e\n\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"low\"\u003eLow\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario is-active\" type=\"button\" data-scenario=\"base\"\u003eBase\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"high\"\u003eHigh\u003c\/button\u003e\n\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-owner-layout\"\u003e\n\u003cform class=\"fml-owner-inputs\"\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMonthly revenue\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Average monthly program revenue before costs. Low, base, and high follow the Year 1, Year 3, and Year 5 planning cases.\"\u003ei\u003cspan role=\"tooltip\"\u003eAverage monthly program revenue before costs. Low, base, and high follow the Year 1, Year 3, and Year 5 planning cases.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"monthlyRevenue\" data-owner-kind=\"money\" data-owner-label=\"Monthly revenue\" data-owner-note=\"Average monthly program revenue before costs. Low, base, and high follow the Year 1, Year 3, and Year 5 planning cases.\" data-low=\"1076583\" data-base=\"3686500\" data-high=\"6608417\" name=\"monthlyRevenue\" type=\"text\" inputmode=\"numeric\" value=\"3,686,500\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eGross margin\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent left after direct device, kit, consumable, referral, and transport costs.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent left after direct device, kit, consumable, referral, and transport costs.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"grossMargin\" data-owner-kind=\"percent\" data-owner-label=\"Gross margin\" data-owner-note=\"Percent left after direct device, kit, consumable, referral, and transport costs.\" name=\"grossMargin\" type=\"range\" min=\"0\" max=\"100\" step=\"1\" data-low=\"80\" data-base=\"82\" data-high=\"85\" value=\"82\"\u003e\u003coutput\u003e82%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eLabor cost\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly staffing cost before owner pay. Includes core clinical and admin wages.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly staffing cost before owner pay. Includes core clinical and admin wages.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"laborCost\" data-owner-kind=\"money\" data-owner-label=\"Labor cost\" data-owner-note=\"Monthly staffing cost before owner pay. Includes core clinical and admin wages.\" data-low=\"145417\" data-base=\"165000\" data-high=\"187917\" name=\"laborCost\" type=\"text\" inputmode=\"numeric\" value=\"165,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eFixed overhead\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly recurring overhead such as lease, insurance, compliance, systems, utilities, and outreach.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly recurring overhead such as lease, insurance, compliance, systems, utilities, and outreach.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"fixedOverhead\" data-owner-kind=\"money\" data-owner-label=\"Fixed overhead\" data-owner-note=\"Monthly recurring overhead such as lease, insurance, compliance, systems, utilities, and outreach.\" data-low=\"225500\" data-base=\"225500\" data-high=\"225500\" name=\"fixedOverhead\" type=\"text\" inputmode=\"numeric\" value=\"225,500\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMarketing\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly physician outreach and demand generation spend.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly physician outreach and demand generation spend.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"marketing\" data-owner-kind=\"money\" data-owner-label=\"Marketing\" data-owner-note=\"Monthly physician outreach and demand generation spend.\" data-low=\"25000\" data-base=\"25000\" data-high=\"25000\" name=\"marketing\" type=\"text\" inputmode=\"numeric\" value=\"25,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eDebt service\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly loan or financing payment. Use 0 if there is no required debt payment.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly loan or financing payment. Use 0 if there is no required debt payment.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"debtService\" data-owner-kind=\"money\" data-owner-label=\"Debt service\" data-owner-note=\"Monthly loan or financing payment. Use 0 if there is no required debt payment.\" data-low=\"0\" data-base=\"0\" data-high=\"0\" name=\"debtService\" type=\"text\" inputmode=\"numeric\" value=\"\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTax reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of operating profit held back before owner distribution.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of operating profit held back before owner distribution.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"taxReserve\" data-owner-kind=\"percent\" data-owner-label=\"Tax reserve\" data-owner-note=\"Percent of operating profit held back before owner distribution.\" name=\"taxReserve\" type=\"range\" min=\"0\" max=\"45\" step=\"1\" data-low=\"20\" data-base=\"15\" data-high=\"12\" value=\"15\"\u003e\u003coutput\u003e15%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eReinvestment reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of operating profit kept for working capital, repairs, and risk buffer.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of operating profit kept for working capital, repairs, and risk buffer.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"reinvestmentReserve\" data-owner-kind=\"percent\" data-owner-label=\"Reinvestment reserve\" data-owner-note=\"Percent of operating profit kept for working capital, repairs, and risk buffer.\" name=\"reinvestmentReserve\" type=\"range\" min=\"0\" max=\"35\" step=\"1\" data-low=\"10\" data-base=\"8\" data-high=\"6\" value=\"8\"\u003e\u003coutput\u003e8%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTarget owner pay\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly owner income target used to calculate the target-pay gap.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly owner income target used to calculate the target-pay gap.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"targetOwnerPay\" data-owner-kind=\"money\" data-owner-label=\"Target owner pay\" data-owner-note=\"Monthly owner income target used to calculate the target-pay gap.\" data-low=\"250000\" data-base=\"500000\" data-high=\"750000\" name=\"targetOwnerPay\" type=\"text\" inputmode=\"numeric\" value=\"500,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/form\u003e\n\u003caside class=\"fml-owner-results\" aria-live=\"polite\"\u003e\u003cspan class=\"fml-owner-tag\"\u003eOwner income output\u003c\/span\u003e\u003cdiv class=\"fml-owner-metrics\"\u003e\n\u003cdiv class=\"fml-owner-metric is-primary\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eOwner Income\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly take-home after tax and reinvestment reserves.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly take-home after tax and reinvestment reserves.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"monthlyOwnerIncome\"\u003e$2M\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eNet Margin\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income divided by monthly revenue.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income divided by monthly revenue.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"netProfitMargin\"\u003e54%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eRevenue for Target Pay\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly revenue needed to support the target owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly revenue needed to support the target owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"revenueNeeded\"\u003e$1.3M\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric is-target-gap is-positive\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eTarget Pay Gap\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income minus target owner pay. Negative means the target pay is not covered.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income minus target owner pay. Negative means the target pay is not covered.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"targetPayGap\"\u003e$1.5M\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdl class=\"fml-owner-result-list\"\u003e\n\u003cdiv\u003e\n\u003cdt\u003eAnnual owner income\u003c\/dt\u003e\n\u003cdd data-owner-output=\"annualOwnerIncome\"\u003e$24,092,664\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eProfit before reserves\u003c\/dt\u003e\n\u003cdd data-owner-output=\"profitBeforeReserves\"\u003e$2,607,430\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTax + reinvestment reserve\u003c\/dt\u003e\n\u003cdd data-owner-output=\"reserveAmount\"\u003e$599,708\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTarget pay gap\u003c\/dt\u003e\n\u003cdd data-owner-output=\"cashAfterTargetPay\"\u003e$1,507,722\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\n\u003cdiv class=\"fml-owner-bridge\"\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"revenue\"\u003e\n\u003cspan\u003eRevenue\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 100%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$3.7M\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"grossProfit\"\u003e\n\u003cspan\u003eGross profit\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 82%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$3M\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"operatingCosts\"\u003e\n\u003cspan\u003eOperating costs\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 11%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$416K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"reserveAmount\"\u003e\n\u003cspan\u003eReserves\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 16%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$600K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"ownerIncome\"\u003e\n\u003cspan\u003eOwner income\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 54%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$2M\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"fml-owner-export\" type=\"button\" data-owner-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-note\"\u003e\n\u003cspan class=\"fml-owner-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e This is a researched planning estimate, not guaranteed salary, tax advice, or owner distribution advice.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003cdiv class=\"container_new_design_blog\"\u003e\n\n\u003cdiv class=\"text-section_blog text-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"line_top_blog\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eNeed the full pro forma view for the Total Artificial Heart Program?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003eYes\u003c\/strong\u003e—this \u003ca href=\"\/products\/total-artificial-heart-financial-model\"\u003eTotal Artificial Heart Program Financial Model Template\u003c\/a\u003e adds the full dashboard, reimbursement, volume, staffing, device and ICU costs, lease, reserves, debt, and owner-income scenarios. It’s the next step after income logic. Open the model.\u003c\/p\u003e\n\n\u003ch4\u003eFull pro forma model highlights\u003c\/h4\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eRevenue charts: $129M to $793M\u003c\/li\u003e\n\u003cli\u003eSurgeons: 2 to 6\u003c\/li\u003e\n\u003cli\u003eCardiologists: 3 to 8\u003c\/li\u003e\n\u003cli\u003eNurses: 12 to 36\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv class=\"image-section_blog image-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"preview-card\" data-preview-src=\"\/cdn\/shop\/files\/total-artificial-heart-financial-model-dashboard-financialmodelslab_52e1e693-8220-49f0-beb1-745594bcf4ab.webp\"\u003e\n\u003cimg class=\"preview-img\" width=\"100%\" height=\"auto\" src=\"\/cdn\/shop\/files\/total-artificial-heart-financial-model-dashboard-financialmodelslab_52e1e693-8220-49f0-beb1-745594bcf4ab.webp?width=500\" alt=\"Total Artificial Heart Program Financial Model dashboard summarizing key KPIs, runway\/cash and performance with a dynamic dashboard for investor-ready reporting and cash-flow blind spot visibility.\"\u003e\n\u003cdiv class=\"preview-overlay\"\u003e\n\u003cbutton class=\"preview-btn\" type=\"button\" style=\"align-items: center; vertical-align: middle; display: inline-flex; justify-content: center; gap: 6px; line-height: 1;\"\u003e\nPREVIEW \u003csvg fill=\"#fff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\" role=\"presentation\" viewbox=\"0 0 448 512\" width=\"14\"\u003e\u003cpath d=\"M416 176V86.63L246.6 256L416 425.4V336c0-8.844 7.156-16 16-16s16 7.156 16 16v128c0 8.844-7.156 16-16 16h-128c-8.844 0-16-7.156-16-16s7.156-16 16-16h89.38L224 278.6L54.63 448H144C152.8 448 160 455.2 160 464S152.8 480 144 480h-128C7.156 480 0 472.8 0 464v-128C0 327.2 7.156 320 16 320S32 327.2 32 336v89.38L201.4 256L32 86.63V176C32 184.8 24.84 192 16 192S0 184.8 0 176v-128C0 39.16 7.156 32 16 32h128C152.8 32 160 39.16 160 48S152.8 64 144 64H54.63L224 233.4L393.4 64H304C295.2 64 288 56.84 288 48S295.2 32 304 32h128C440.8 32 448 39.16 448 48v128C448 184.8 440.8 192 432 192S416 184.8 416 176z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhich Total Artificial Heart Program costs reduce take-home most?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eIf you’re asking which costs cut take-home most in a \u003ca href=\"\/blogs\/startup-costs\/total-artificial-heart\"\u003eHow Much To Start A Total Artificial Heart Program?\u003c\/a\u003e setup, the biggest drag is \u003cstrong\u003edevice and surgical kits\u003c\/strong\u003e: they run at \u003cstrong\u003e120%\u003c\/strong\u003e of revenue in Year 1 and still \u003cstrong\u003e100%\u003c\/strong\u003e in Year 5. That’s before specialized consumables, referral partner costs, and transport; the known direct cost load is \u003cstrong\u003e205%\u003c\/strong\u003e in Year 1 and \u003cstrong\u003e152%\u003c\/strong\u003e in Year 5, so the model is underwater unless other economics are much better.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMain cost drains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDevice and surgical kits: \u003cstrong\u003e120%\u003c\/strong\u003e to \u003cstrong\u003e100%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSpecialized consumables: \u003cstrong\u003e30%\u003c\/strong\u003e to \u003cstrong\u003e22%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eReferral partner costs: \u003cstrong\u003e40%\u003c\/strong\u003e to \u003cstrong\u003e20%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eTransport and logistics: \u003cstrong\u003e15%\u003c\/strong\u003e to \u003cstrong\u003e10%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat’s still missing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePayroll is not included\u003c\/li\u003e\n\u003cli\u003eICU days are not included\u003c\/li\u003e\n\u003cli\u003eBlood products and imaging are missing\u003c\/li\u003e\n\u003cli\u003eInfection care, readmissions, debt service, reserves\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow many total artificial heart implants are needed to be profitable?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eThe Total Artificial Heart Program needs reimbursement to exceed direct case costs plus fixed readiness costs; the provided model uses \u003cstrong\u003e192 implants in Year 1\u003c\/strong\u003e, \u003cstrong\u003e672 in Year 3\u003c\/strong\u003e, and \u003cstrong\u003e1,152 in Year 5\u003c\/strong\u003e as the operating scale, not a confirmed break-even count. For the plan math behind this, see \u003ca href=\"\/blogs\/write-business-plan\/total-artificial-heart\"\u003eHow Do I Write A Business Plan To Launch Total Artificial Heart Program?\u003c\/a\u003e, because a \u003cstrong\u003e$144M annual facility lease\u003c\/strong\u003e makes low volume owner income highly volatile.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVolume targets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eYear 1 model: \u003cstrong\u003e192 implants\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eYear 3 model: \u003cstrong\u003e672 implants\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eYear 5 model: \u003cstrong\u003e1,152 implants\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eLease load: \u003cstrong\u003e$144M per year\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eProfit gates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBeat direct case costs\u003c\/li\u003e\n\u003cli\u003eControl cost load from \u003cstrong\u003e205% to 152%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSecure payer authorization\u003c\/li\u003e\n\u003cli\u003eFund payroll, debt, compliance, capacity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eIs a Total Artificial Heart Program profitable for an owner?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eThe \u003cstrong\u003eTotal Artificial Heart Program\u003c\/strong\u003e can be financially feasible inside a larger medical center, but it is much harder as a standalone site. Here’s the quick math: model revenue grows from \u003cstrong\u003e$129M\u003c\/strong\u003e to \u003cstrong\u003e$793M\u003c\/strong\u003e over \u003cstrong\u003e5 years\u003c\/strong\u003e, and known operating profit before unprovided payroll and reserves rises from about \u003cstrong\u003e$88M\u003c\/strong\u003e to \u003cstrong\u003e$658M\u003c\/strong\u003e. That only works if referral depth, transplant alignment, \u003cstrong\u003e24\/7\u003c\/strong\u003e clinical coverage, payer contracts, outcomes, and capital reserves all support volume.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhy it can work\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e$129M\u003c\/strong\u003e to \u003cstrong\u003e$793M\u003c\/strong\u003e revenue path\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$88M\u003c\/strong\u003e to \u003cstrong\u003e$658M\u003c\/strong\u003e operating profit\u003c\/li\u003e\n\u003cli\u003eBest fit: larger medical center\u003c\/li\u003e\n\u003cli\u003eNeeds steady referral and transplant flow\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhy standalone is tougher\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReadiness costs stay high\u003c\/li\u003e\n\u003cli\u003eReimbursement can move around\u003c\/li\u003e\n\u003cli\u003eRegulation raises setup burden\u003c\/li\u003e\n\u003cli\u003eCapital barriers limit early scale\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhich drivers move owner income most?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-main-income-drivers\" aria-label=\"Main income drivers card grid for the total artificial heart program.\"\u003e\u003carticle class=\"driver-option is-cards\"\u003e\u003cdiv class=\"main-driver-grid\"\u003e\n\u003carticle class=\"main-driver-card is-primary\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e1\u003c\/span\u003e\u003ch4\u003eImplant Volume\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e192-1,152\u003c\/strong\u003e\u003cp\u003eMore implants spread fixed costs faster and lift owner take-home the most.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e2\u003c\/span\u003e\u003ch4\u003ePayer Mix\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$450K-$506K\u003c\/strong\u003e\u003cp\u003eHigher reimbursement per case raises revenue before the program hits labor and facility costs.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e3\u003c\/span\u003e\u003ch4\u003eDirect Costs\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e20.5%-15.2%\u003c\/strong\u003e\u003cp\u003eLower device, consumable, commission, and logistics load keeps more gross margin per implant.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e4\u003c\/span\u003e\u003ch4\u003eStaffing Model\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e23-64 roles\u003c\/strong\u003e\u003cp\u003eClinical headcount growth must stay close to volume or wages will eat EBITDA.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e5\u003c\/span\u003e\u003ch4\u003eReferral Network\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e4.0%-2.0%\u003c\/strong\u003e\u003cp\u003eStronger referral flow reduces paid partner commissions and keeps the pipeline full.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e6\u003c\/span\u003e\u003ch4\u003eICU Outcomes\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$2.71M\u003c\/strong\u003e\u003cp\u003eShorter ICU stays protect capacity and stop annual fixed overhead from diluting margin.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/article\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eTotal Artificial Heart Program Core Six Income Drivers\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eAnnual Implant Volume\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"left-row1\"\u003e\n\u003ch3\u003eAnnual Implant Volume\u003c\/h3\u003e\n\u003cp\u003eAnnual implant volume drives \u003cstrong\u003efixed-cost absorption\u003c\/strong\u003e—that means spreading the \u003cstrong\u003e$144M facility lease\u003c\/strong\u003e and ready staffing over more cases. Going from \u003cstrong\u003e192 implants in Year 1\u003c\/strong\u003e to \u003cstrong\u003e1,152 in Year 5\u003c\/strong\u003e can improve margin and owner pay, but only if those implants are authorized, scheduled, and completed without wasting ICU time.\u003c\/p\u003e\n\u003cp\u003eVolume alone does not create profit. Revenue grows only if cardiac surgeon capacity rises from \u003cstrong\u003e400%\u003c\/strong\u003e to \u003cstrong\u003e800%\u003c\/strong\u003e, because more qualified cases must pass through the same operating room, ICU, and follow-up team. If authorizations fail, ICU days stretch, or readmissions rise, the extra volume can raise costs faster than cash comes in.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"right-row1\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eTrack Qualified Cases\u003c\/h3\u003e\n\u003cp\u003eMeasure \u003cstrong\u003equalified authorized implants\u003c\/strong\u003e, not just referrals. Track monthly implants, authorization rate, ICU length of stay, readmissions, and fixed cost per case. That tells you whether volume is actually lowering overhead per implant and improving cash the owner can draw.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonthly implants\u003c\/strong\u003e: 192 to 1,152 path\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAuthorization rate\u003c\/strong\u003e: no approval, no revenue\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eICU days\u003c\/strong\u003e: drives nursing cost\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReadmissions\u003c\/strong\u003e: can erase margin\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBuild a base, upside, and stress forecast. If case flow is strong but capacity stays near \u003cstrong\u003e400%\u003c\/strong\u003e, the program stays underused; if capacity climbs toward \u003cstrong\u003e800%\u003c\/strong\u003e and cases stay clean, fixed costs get spread better and take-home income improves.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step1\"\u003e1\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eReimbursement And Payer Mix\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row2\"\u003e\n    \u003ch3\u003eReimbursement And Payer Mix\u003c\/h3\u003e\n    \u003cp\u003e\u003cstrong\u003eReimbursement\u003c\/strong\u003e is the net money you keep per total artificial heart case after payer rules, denials, and collections. Even at the same implant volume, episode pricing moves from \u003cstrong\u003e$450,000\u003c\/strong\u003e in Year 1 to \u003cstrong\u003e$506,479\u003c\/strong\u003e in Year 5, a lift of \u003cstrong\u003e$56,479\u003c\/strong\u003e or about \u003cstrong\u003e12.6%\u003c\/strong\u003e. That change hits revenue, gross margin, and owner pay fast.\u003c\/p\u003e\n    \u003cp\u003e\u003cstrong\u003ePayer mix\u003c\/strong\u003e changes cash timing, not just price. Medicare, commercial insurance, and negotiated rates can shift authorization rate, denial rate, and collection lag, so the same case load can produce very different cash reserves. Cardiology, perfusion, nursing, and device technician management revenue also adds income, but only if it is actually authorized and collected.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row2\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack payer mix, not just case count\u003c\/h3\u003e\n      \u003cp\u003eBuild the model around \u003cstrong\u003eMedicare\u003c\/strong\u003e, \u003cstrong\u003ecommercial insurance\u003c\/strong\u003e, \u003cstrong\u003enegotiated rates\u003c\/strong\u003e, \u003cstrong\u003eauthorization rate\u003c\/strong\u003e, \u003cstrong\u003edenial rate\u003c\/strong\u003e, and \u003cstrong\u003ecollection lag\u003c\/strong\u003e. Here’s the quick math: same volume, different mix, different cash. If one payer delays payment or denies more often, the program needs more working capital even when revenue looks stable on paper.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eTrack net revenue by payer\u003c\/li\u003e\n        \u003cli\u003eSeparate managed-care and episode income\u003c\/li\u003e\n        \u003cli\u003eMeasure days to cash\u003c\/li\u003e\n        \u003cli\u003eReview denied claims weekly\u003c\/li\u003e\n      \u003c\/ul\u003e\n      \u003cp\u003eNever treat modeled reimbursement as guaranteed. If authorization slips or denials rise, owner draw gets squeezed before volume shows the problem. The cleanest control is to forecast cash by payer, then stress test the model for slower collections and lower approved case rates.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step2\"\u003e2\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eDevice And Direct Clinical Costs\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"left-row3\"\u003e\n\u003ch3\u003eDirect Device Cost Load\u003c\/h3\u003e\n\u003cp\u003eThis is the main margin lever per total artificial heart case. In the model, device and surgical kits run \u003cstrong\u003e120%\u003c\/strong\u003e of revenue in Year 1 and \u003cstrong\u003e100%\u003c\/strong\u003e in Year 5, consumables add \u003cstrong\u003e30%\u003c\/strong\u003e to \u003cstrong\u003e22%\u003c\/strong\u003e, and referral plus logistics add \u003cstrong\u003e55%\u003c\/strong\u003e to \u003cstrong\u003e30%\u003c\/strong\u003e; that cost mix decides how much cash is left for fixed overhead and owner pay.\u003c\/p\u003e\n\u003cp\u003eTrack \u003cstrong\u003ecost per case\u003c\/strong\u003e, not just volume. If a case brings in the same fee but kit, consumable, or transport spend rises, contribution margin shrinks fast; the model shows a lift from \u003cstrong\u003e795%\u003c\/strong\u003e to \u003cstrong\u003e848%\u003c\/strong\u003e before fixed costs when direct load falls, so every point saved here drops straight to profit and draw.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"right-row3\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eControl Cost Per Case\u003c\/h3\u003e\n\u003cp\u003eBuild each case around one file: \u003cstrong\u003eepisode revenue\u003c\/strong\u003e, device kit cost, consumables, and referral\/logistics. Then compare actual spend to the modeled percentages every month. One line tells you the truth: \u003cstrong\u003edirect cost per case ÷ case revenue\u003c\/strong\u003e. If that ratio drifts up, owner cash gets squeezed before fixed costs are even paid.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMeasure cost by case ID.\u003c\/li\u003e\n\u003cli\u003eSeparate kits from consumables.\u003c\/li\u003e\n\u003cli\u003eAudit logistics and referral spend.\u003c\/li\u003e\n\u003cli\u003eFlag any case over target.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step3\"\u003e3\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eSpecialist Staffing Model\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row4\"\u003e\n    \u003ch3\u003eSpecialist Staffing Load\u003c\/h3\u003e\n    \u003cp\u003eThis driver is the cost of keeping a \u003cstrong\u003e24\/7 total artificial heart team\u003c\/strong\u003e ready before cases arrive. Headcount rises from \u003cstrong\u003e2 to 6 cardiac surgeons\u003c\/strong\u003e, \u003cstrong\u003e3 to 8 heart failure cardiologists\u003c\/strong\u003e, \u003cstrong\u003e4 to 8 perfusionists\u003c\/strong\u003e, \u003cstrong\u003e12 to 36 critical care nurses\u003c\/strong\u003e, and \u003cstrong\u003e2 to 6 device technicians\u003c\/strong\u003e. Low volume hurts take-home because salaries, benefits, call coverage, billing staff, and device coordination are partly fixed even when case count is thin.\u003c\/p\u003e\n    \u003cp\u003eThe key pressure point is \u003cstrong\u003efixed readiness versus variable case labor\u003c\/strong\u003e. If authorized cases do not fill the schedule, payroll sits ahead of revenue and owner draw gets squeezed. What this estimate hides is the dollar pay rate, so the real test is whether staffed capacity stays high enough to spread coverage costs across enough implants and follow-up care.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row4\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Readiness, Not Just Headcount\u003c\/h3\u003e\n      \u003cp\u003eTrack \u003cstrong\u003eFTEs\u003c\/strong\u003e, paid call hours, case volume, and staffed-to-case ratio every month. Build the model with separate lines for \u003cstrong\u003esalaries\u003c\/strong\u003e, \u003cstrong\u003ebenefits\u003c\/strong\u003e, \u003cstrong\u003ecall coverage\u003c\/strong\u003e, billing, and device coordination, because those costs hit even before the next implant is booked. That is the quick math: more ready staff helps access, but only if volume is there to absorb them.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eMatch staffing to authorized cases.\u003c\/li\u003e\n        \u003cli\u003eMonitor idle coverage hours.\u003c\/li\u003e\n        \u003cli\u003eForecast pay against implant volume.\u003c\/li\u003e\n        \u003cli\u003eSeparate fixed and case labor.\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step4\"\u003e4\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eICU Length Of Stay And Outcomes\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row5\"\u003e\n    \u003ch3\u003eICU Stay Per Case\u003c\/h3\u003e\n    \u003cp\u003e\u003cstrong\u003eICU length of stay\u003c\/strong\u003e is a margin driver because every extra day adds nursing, supplies, imaging, blood products, and complication costs before the case can clear to the next phase of care. For total artificial heart patients, post-implant management revenue helps, but longer ICU time can still wipe out contribution margin if labor and consumables rise faster than collections.\u003c\/p\u003e\n    \u003cp\u003eHere’s the quick math: the program’s critical care nursing load rises from \u003cstrong\u003e12 nurses at 600% capacity\u003c\/strong\u003e to \u003cstrong\u003e36 nurses at 850% capacity\u003c\/strong\u003e. That means bed-days are expensive, so the owner’s take-home income depends on keeping ICU days tight enough to protect margin and free capacity for more billable cases.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row5\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack ICU Days And Cost Per Stay\u003c\/h3\u003e\n      \u003cp\u003eMeasure \u003cstrong\u003eaverage ICU days per implant\u003c\/strong\u003e, nursing hours per patient, and direct ICU cost p\ner case. Also track imaging, blood products, readmissions, and transplant timing, since each one can push cash out before payment catches up. If ICU days drift up, the program may need more nurses or higher reserve cash, which cuts owner draw.\u003c\/p\u003e\n      \u003cp\u003eUse a simple sensitivity check: hold implant volume and reimbursement flat, then test how one extra ICU day changes margin. If the added nursing and supply cost exceeds the post-implant management revenue on that case, the owner earns less even when clinical throughput looks busy. That is the real pressure point.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step5\"\u003e5\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eReferral Network Strength\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row6\"\u003e\n    \u003ch3\u003eReferral Network Strength\u003c\/h3\u003e\n    \u003cp\u003e\u003cstrong\u003eReferral network strength\u003c\/strong\u003e is how well the program turns cardiology, transplant, emergency department, insurer, and regional hospital relationships into \u003cstrong\u003eauthorized, clinically appropriate cases\u003c\/strong\u003e. It drives implant volume, follow-up visits, and post-implant management, so weak referrals leave readiness costs underused and cut owner profit even when clinical skill is strong.\u003c\/p\u003e\n    \u003cp\u003eTrack \u003cstrong\u003ereferrals received\u003c\/strong\u003e, \u003cstrong\u003eauthorization rate\u003c\/strong\u003e, \u003cstrong\u003econversion to implant\u003c\/strong\u003e, payer mix, and days from referral to approval. Here’s the quick math: more covered cases raise revenue and cash flow, but denials or slow approvals keep surgeons, ICU, and coordination capacity idle, which lowers the owner’s take-home pay.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row6\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eMeasure and Tighten Referral Flow\u003c\/h3\u003e\n      \u003cp\u003eBuild the model by source, not as one lump. Split referrals from cardiologists, transplant centers, emergency departments, insurers, and regional hospitals, then tag each case by payer and approval status. The goal is not more leads; it’s more \u003cstrong\u003ebillable, covered cases\u003c\/strong\u003e that can move to implant and long-term care.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eCount referrals by source.\u003c\/li\u003e\n        \u003cli\u003eTrack approval days.\u003c\/li\u003e\n        \u003cli\u003eWatch denial and appeal rates.\u003c\/li\u003e\n        \u003cli\u003eMeasure implant conversion.\u003c\/li\u003e\n        \u003cli\u003eLink follow-ups to each case.\u003c\/li\u003e\n      \u003c\/ul\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step6\"\u003e6\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eCompare low, base, and high owner-income scenarios\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-scenario-table\" aria-label=\"Total Artificial Heart Program Owner Income Scenarios.\" data-site-name=\"Financial Models Lab\" data-site-url=\"https:\/\/financialmodelslab.com\" data-source-title=\"Total Artificial Heart Program Owner Income Scenarios.\" data-note-label=\"Planning note\" data-note-text=\"These scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\"\u003e\u003cdiv class=\"fml-scenario-table-card\"\u003e\n\u003cheader class=\"fml-scenario-table-header\"\u003e\u003cdiv\u003e\n\u003cp class=\"fml-scenario-table-eyebrow\"\u003eScenario table\u003c\/p\u003e\n\u003cp class=\"fml-scenario-table-description\"\u003eOwner income moves with implant volume, staffing, and reimbursement. Low, base, and high cases show how fixed clinical costs and payer mix shape take-home profit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-actions\"\u003e\u003cbutton class=\"fml-scenario-table-export\" type=\"button\" data-scenario-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-scenario-table-wrap\"\u003e\u003ctable class=\"fml-scenario-table-grid\"\u003e\n\u003ccaption\u003eCompare low, base, and high income cases for the program.\u003c\/caption\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth class=\"fml-scenario-table-stub\" scope=\"col\" data-export-value=\"Scenario\"\u003eScenario\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Low Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eLow Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eLow volume risk\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Base Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eBase Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eStaffing intensity\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"High Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eHigh Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eReimbursement sensitivity\u003c\/span\u003e\n\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Launch model\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-launch\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-launch-model.svg\" alt=\"Launch model icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eLaunch model\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"This is the lower earnings path, with Year 1 volume and a tighter spread between revenue and costs.\"\u003eThis is the lower earnings path, with Year 1 volume and a tighter spread between revenue and costs.\u003c\/td\u003e\n\u003ctd data-export-value=\"This is the modeled middle path, with Year 3 scale and steady throughput.\"\u003eThis is the modeled middle path, with Year 3 scale and steady throughput.\u003c\/td\u003e\n\u003ctd data-export-value=\"This is the stronger earnings path, with Year 5 scale and the widest operating spread.\"\u003eThis is the stronger earnings path, with Year 5 scale and the widest operating spread.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Typical setup\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-setup\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-typical-setup.svg\" alt=\"Typical setup icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eTypical setup\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Year 1 volume is 192 implants with about $129M revenue, a 795% contribution margin, and about $88M known profit before payroll, debt, taxes, and reserves.\"\u003eYear 1 volume is 192 implants with about $129M revenue, a 795% contribution margin, and about $88M known profit before payroll, debt, taxes, and reserves.\u003c\/td\u003e\n\u003ctd data-export-value=\"Year 3 volume is 672 implants with about $442M revenue, an 821% contribution margin, and about $349M known profit before payroll, debt, taxes, and reserves.\"\u003eYear 3 volume is 672 implants with about $442M revenue, an 821% contribution margin, and about $349M known profit before payroll, debt, taxes, and reserves.\u003c\/td\u003e\n\u003ctd data-export-value=\"Year 5 volume reaches 1,152 implants with about $793M revenue, an 848% contribution margin, and about $658M known profit before payroll, debt, taxes, and reserves.\"\u003eYear 5 volume reaches 1,152 implants with about $793M revenue, an 848% contribution margin, and about $658M known profit before payroll, debt, taxes, and reserves.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Cost drivers\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-drivers\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-cost-drivers.svg\" alt=\"Cost drivers icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eCost drivers\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Low implant volume; fixed staffing load; referral commissions; device and surgical kit costs; reimbursement pressure\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eLow implant volume\u003c\/li\u003e\n\u003cli\u003efixed staffing load\u003c\/li\u003e\n\u003cli\u003ereferral commissions\u003c\/li\u003e\n\u003cli\u003edevice and surgical kit costs\u003c\/li\u003e\n\u003cli\u003ereimbursement pressure\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"Steady implant volume; larger clinical team; referral commissions; facility and compliance overhead; reimbursement mix\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eSteady implant volume\u003c\/li\u003e\n\u003cli\u003elarger clinical team\u003c\/li\u003e\n\u003cli\u003ereferral commissions\u003c\/li\u003e\n\u003cli\u003efacility and compliance overhead\u003c\/li\u003e\n\u003cli\u003ereimbursement mix\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"High implant volume; bigger nursing bench; more surgeon coverage; higher compliance load; payer mix pressure\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eHigh implant volume\u003c\/li\u003e\n\u003cli\u003ebigger nursing bench\u003c\/li\u003e\n\u003cli\u003emore surgeon coverage\u003c\/li\u003e\n\u003cli\u003ehigher compliance load\u003c\/li\u003e\n\u003cli\u003epayer mix pressure\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Owner income range\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-range\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-planning-range.svg\" alt=\"Owner income range icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eOwner income range\u003c\/span\u003e\u003cspan class=\"fml-scenario-row-subtitle\"\u003eBefore owner reserves\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"$88M\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$88M\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eVolume risk\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$349M\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$349M\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eCore plan\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$658M\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$658M\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eUpside case\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Best fit\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-fit\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-best-fit.svg\" alt=\"Best fit icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eBest fit\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Use this to stress-test cash flow if volumes stay near launch levels and payer collection is slow.\"\u003eUse this to stress-test cash flow if volumes stay near launch levels and payer collection is slow.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this as the working plan for budgets, hiring, and lender talks.\"\u003eUse this as the working plan for budgets, hiring, and lender talks.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this to test upside if capacity, staffing, and reimbursement all hold.\"\u003eUse this to test upside if capacity, staffing, and reimbursement all hold.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-note\"\u003e\n\u003cspan class=\"fml-scenario-table-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e These scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304461115635,"sku":"total-artificial-heart-owner-makes","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/total-artificial-heart-owner-makes.webp?v=1782694030","url":"https:\/\/financialmodelslab.com\/products\/total-artificial-heart-owner-makes","provider":"Financial Models Lab","version":"1.0","type":"link"}